High Prevalence of Secondary Hyperparathyroidism in Patients Under Regular Hemodialysis in Brack-Alshati General hospital
Article Sidebar
Deprecated: Return type of Carbon\Carbon::createFromTimestamp($timestamp, $tz = null) should either be compatible with DateTime::createFromTimestamp(int|float $timestamp): static, or the #[\ReturnTypeWillChange] attribute should be used to temporarily suppress the notice in /home/sebha/public_html/journal/lib/pkp/lib/vendor/nesbot/carbon/src/Carbon/Traits/Timestamp.php on line 29
January 12, 2023
-
Chronic Kidney Disease, Hemodialysis, Scondery Hyperparathyrodism, Minerals, Elecrolytes
Abstract
Secondary hyperparathyroidism is a common complication of chronic kidney disease. We estimated serum parathyroid hormone and some minerals in 46 patients undergoing hemodialysis treatment in the dialysis center at Brack Alshati General Hospital during September 2021 to October 2021. Before dialysis, a blood sample was collected for assessment of PTH level and minerals, including calcium, phosphorus, sodium, and potassium. The mean age of the patients was 45.37±17.14 years. The mean concentration of PTH for the study group was 826.77 ± 646.86 pg/ml. The prevalence of secondary hyperparathyroidism (SHPT) among the patients was 73.91%. We conclude that SHPT is highly prevalent in our hemodialysis population and has serious outcomes for the health of patients. If it is poorly overcome, this imbalance can result in the bone disease, calcification of soft tissue, and vascular calcification; all of these are found to be influential on mortality and morbidity.
Full text article
References
[1]-Levey, A.S., et al., Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO).Kidney international, 2005. 67(6): p. 2089-2100.
[2]-Chen, T.K., D.H. Knicely, and M.E. Grams, Chronic kidney disease diagnosis and management: a review.Jama, 2019. 322(13): p. 1294-1304.
[3]-Cotoi, L., et al., Thyroid Pathology in End-Stage Renal Disease Patients on Hemodialysis.Diagnostics, 2020. 10(4): p. 245.
[4]-Li, J., et al., Correlates of parathyroid hormone concentration in hemodialysis patients.Nephrology Dialysis Transplantation, 2013. 28(6): p. 1516-1525.
[5]-Kovesdy, C., et al., Secondary hyperparathyroidism is associated with higher mortality in men with moderate to severe chronic kidney disease.Kidney international, 2008. 73(11): p. 1296-1302.
[6]-Cozzolino, M., et al., Parathyroid Glands in CKD: Anatomy, Histology, Physiology and Molecular Biology in CKD, in Parathyroid Glands in Chronic Kidney Disease. 2020, Springer. p. 1-19.
[7]-Tomasello, S., Secondary hyperparathyroidism and chronic kidney disease.Diabetes Spectrum, 2008. 21(1): p. 19-25.
[8]-Gimba, Z.M., et al., Secondary hyperparathyroidism among Nigerians with chronic kidney disease.African health sciences, 2018. 18(2): p. 446-457.
[9]-Ahmed, H.A., et al., Prevalence of mineral bone disorders among hemodialysis patients in Menoufia Governorate, Egypt.Menoufia Medical Journal, 2017. 30(3): p. 687.
[10]-Zhou, X., Y. Guo, and Y. Luo, The optimal range of serum intact parathyroid hormone for a lower risk of mortality in the incident hemodialysis patients.Renal failure, 2021. 43(1): p. 599-605.
[11]-Fathima, R., & Rao, C. U. (2021). Study of the Prevalence and Severity of Disordered Mineral Metabolism in Patients with Chronic Kidney Disease Stage-5 on Hemodialysis.Journal of Contemporary Medicine and Dentistry, 2021. 9(2): p. 8-12
[12]-Owda, A., et al., Secondary hyperparathyroidism in chronic hemodialysis patients: prevalence and race.Renal failure, 2003. 25(4): p. 595-602.
[13]-Mahmoud, M., N.A.E. Zaki, and A.T. Ali, Study of hyperparathyroidism among patients with chronic kidney disease at sohag university hospital.Sohag Medical Journal, 2017. 21(3): p. 367-380.
[14]-Wei, J. H., Lee, W. J., Chong, K., Lee, Y. C., Chen, S. C., Huang, P. H., & Lin, S. J. (2018). High incidence of secondary hyperparathyroidism in bariatric patients: comparing different procedures.Obesity surgery,28(3), 798-804.
[15]-Xu, Y., et al., Secondary hyperparathyroidism and adverse health outcomes in adults with chronic kidney disease. Clinical Kidney Journal, 2021
[16]-14.Arora, K., et al., Correlation of parathyroid hormone levels with mineral status in end-stage renal disease patients.Indian journal of endocrinology and metabolism, 2018. 22(6): p. 735.
[17]-Abdelgader, N.I. and A. Abdrabo, Serum calcium, phosphorous, and parathyroid hormone in Sudanese patients under regular haemodialysis.American Journal of Research Communication, 2013. 1(12): p. 353-359.
[18]-Silver, J., R. Kilav, and T. Naveh-Many, Mechanisms of secondary hyperparathyroidism. American Journal of Physiology-Renal Physiology, 2002. 283(3): p. F367-F376
[19]-Rahimian, M., R. Sami, and F. Behzad, Evaluation of secondary hyperparathyroidism in patients undergoing hemodialysis.Saudi Journal of Kidney Diseases and Transplantation, 2008. 19(1): p. 116.
[20]-Owiredu, W., et al., Relationship between parathyroid hormone and electrolytes in chronic kidney disease.E3 Journal of Medical Research, 2012. 1(8): p. 103-111.
[21]-Jannot, M., et al., Evolution of secondary hyperparathyroidism in patients following return to hemodialysis after kidney transplant failure.Nephrologie & therapeutique, 2020. 16(2): p. 118-123.
[22]-Cantor T, Sci B. The assay of the hypocalcemic PTH fragment inhibitor with PTH provides a more accurate assessment of renal osteodystrophy compared to the intact PTH assay. Nefrologia 2003;23:69-72.
[23]-21.KOVESDY, C., AHMADZADEH, S., ANDERSON, J. & KALANTAR-ZADEH, K. 2008. Secondary hyperparathyroidism is associated with higher mortality in men with moderate to severe chronic kidney disease. Kidney international, 73, 1296-1302.
[24]-FUJII, H. 2018. Association between parathyroid hormone and cardiovascular disease. Therapeutic Apheresis and Dialysis,22,236-241.
Authors
Copyright (c) 2022 Journal of Pure & Applied Sciences
This work is licensed under a Creative Commons Attribution 4.0 International License.
In a brief statement, the rights relate to the publication and distribution of research published in the journal of the University of Sebha where authors who have published their articles in the journal of the university of Sebha should how they can use or distribute their articles. They reserve all their rights to the published works, such as (but not limited to) the following rights:
- Copyright and other property rights related to the article, such as patent rights.
- Research published in the journal of the University of Sebha and used in its future works, including lectures and books, the right to reproduce articles for their own purposes, and the right to self-archive their articles.
- The right to enter a separate article, or for a non-exclusive distribution of their article with an acknowledgment of its initial publication in the journal of Sebha University.
Privacy Statement The names and e-mail addresses entered on the Sabha University Journal site will be used for the aforementioned purposes only and for which they were used.